
Results
46
These companies have grown profits at a double digit rate for 5 years or more. And they have net cash.
46 companies
SK Biopharmaceuticals
Market Cap: ₩10.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩139,800.00
7D
10.5%
1Y
35.2%
Abbott India
Market Cap: ₹639.0b
Operates as a pharmaceutical company in India.
500488
₹30,069.35
7D
1.7%
1Y
8.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥44.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥98.29
7D
2.9%
1Y
60.8%
Imeik Technology DevelopmentLtd
Market Cap: CN¥43.8b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥145.37
7D
-1.8%
1Y
-31.4%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹434.8b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,566.65
7D
2.8%
1Y
4.9%
Chengdu Kanghong Pharmaceutical Group
Market Cap: CN¥29.0b
Engages in the research, development, manufacture, and distribution of medicine for ophthalmic, neuropsychiatric and other applications in China.
002773
CN¥31.50
7D
4.6%
1Y
53.8%
Camurus
Market Cap: SEK 36.8b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 617.00
7D
1.6%
1Y
8.2%
BioArctic
Market Cap: SEK 27.0b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 304.60
7D
9.2%
1Y
57.7%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.6b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س151.00
7D
0.8%
1Y
-3.9%
AstraZeneca Pharma India
Market Cap: ₹226.2b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,048.30
7D
0.6%
1Y
37.9%
Anhui Anke Biotechnology (Group)
Market Cap: CN¥16.5b
Anhui Anke Biotechnology (Group) Co., Ltd.
300009
CN¥9.88
7D
0.1%
1Y
10.4%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥13.7b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥21.72
7D
0.4%
1Y
6.6%
Stoke Therapeutics
Market Cap: US$1.8b
An early-stage biopharmaceutical company, engages in the development of treatments for severe genetic diseases by upregulating protein expression.
STOK
US$30.91
7D
5.4%
1Y
155.2%
Concord Biotech
Market Cap: ₹148.3b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,417.60
7D
-0.7%
1Y
-33.4%
Neuren Pharmaceuticals
Market Cap: AU$2.5b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$19.64
7D
8.2%
1Y
57.5%
Changzhou Qianhong BiopharmaLTD
Market Cap: CN¥10.5b
Manufactures and distributes polysaccharide and protease drugs in China.
002550
CN¥8.43
7D
2.2%
1Y
33.6%
Indegene
Market Cap: ₹127.5b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹531.30
7D
4.2%
1Y
-22.1%
Bonesupport Holding
Market Cap: SEK 13.3b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 201.80
7D
5.4%
1Y
-44.9%
Blue Jet Healthcare
Market Cap: ₹100.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹578.45
7D
4.2%
1Y
11.4%
Soho Global Health
Market Cap: Rp18.6t
Together with its subsidiaires, operates as a healthcare company in Indonesia.
SOHO
Rp1,465.00
7D
-13.6%
1Y
122.0%
BioGaia
Market Cap: SEK 10.2b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.90
7D
-0.4%
1Y
-5.7%
Theravance Biopharma
Market Cap: US$1.0b
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$20.30
7D
9.8%
1Y
119.5%
Zhejiang Yatai Pharmaceutical
Market Cap: CN¥5.8b
Researches, produces, sells, and exports pharmaceutical products in China and internationally.
002370
CN¥7.72
7D
4.6%
1Y
117.5%
Tibet Weixinkang Medicine
Market Cap: CN¥4.9b
Engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China.
603676
CN¥11.30
7D
3.1%
1Y
6.9%
Sunmax Biotechnology
Market Cap: NT$21.3b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$391.50
7D
0.1%
1Y
40.8%
Zentiva
Market Cap: RON 3.2b
Engages in the production and marketing of preparations and medicines for human use in Romania and internationally.
SCD
RON 4.52
7D
0%
1Y
55.9%
Onconic Therapeutics
Market Cap: ₩923.2b
Engages in the research and development of anti-cancer therapy in South Korea.
A476060
₩20,750.00
7D
21.1%
1Y
n/a
Handa Pharmaceuticals
Market Cap: NT$18.8b
A specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States.
6620
NT$120.00
7D
2.6%
1Y
123.5%
SMO ClinPlusLTD
Market Cap: CN¥3.6b
Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.
301257
CN¥46.02
7D
5.6%
1Y
47.0%
Ever Supreme Bio Technology
Market Cap: NT$15.1b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$172.00
7D
4.2%
1Y
7.2%
GlaxoSmithKline Pakistan
Market Cap: PK₨127.2b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨399.48
7D
2.6%
1Y
9.4%
RPG Life Sciences
Market Cap: ₹37.7b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,278.10
7D
1.1%
1Y
2.7%
Novartis India
Market Cap: ₹19.9b
Novartis India Limited is involved in the pharmaceutical business in India.
500672
₹807.75
7D
-2.8%
1Y
-25.9%
Savior Lifetec
Market Cap: NT$5.7b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$18.20
7D
5.2%
1Y
-12.1%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.4b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹215.52
7D
6.9%
1Y
-29.2%
Quality Chemical Industries
Market Cap: USh420.0b
Manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh115.01
7D
-3.4%
1Y
105.4%